Filing Details
- Accession Number:
- 0001073397-15-000021
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-03 19:08:56
- Reporting Period:
- 2015-08-03
- Filing Date:
- 2015-08-03
- Accepted Time:
- 2015-08-03 19:08:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
883984 | Icu Medical Inc | ICUI | Surgical & Medical Instruments & Apparatus (3841) | 330022692 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1189724 | Steven Riggs | 951 Calle Amanecer San Clemente CA 92673 | Vp Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-08-03 | 9,983 | $37.00 | 13,098 | No | 4 | X | Direct | |
Common Stock | Disposition | 2015-08-03 | 9,983 | $100.00 | 3,115 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2015-08-03 | 15,000 | $43.12 | 18,115 | No | 4 | X | Direct | |
Common Stock | Disposition | 2015-08-03 | 15,000 | $100.00 | 3,115 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | X | Direct | |
No | 4 | S | Direct | |
No | 4 | X | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2015-08-03 | 9,983 | $0.00 | 9,983 | $37.00 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2015-08-03 | 15,000 | $0.00 | 15,000 | $43.12 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2020-07-21 | No | 4 | X | Direct | |
0 | 2021-02-02 | No | 4 | X | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on May 20, 2015.
- Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.
- Transaction is the exercise of a derivative security; see Column 2.